Luis Alvarez
Vorstandsvorsitzender bei Theradaptive, Inc.
Profil
Luis Alvarez is the founder of Elevian, Inc., Theradaptive, Inc. He has a graduate and doctorate degree from the Massachusetts Institute of Technology.
Aktive Positionen von Luis Alvarez
| Unternehmen | Position | Beginn |
|---|---|---|
Theradaptive, Inc.
 Theradaptive, Inc. Packaged SoftwareTechnology Services Theradaptive, Inc. is a venture-backed biopharmaceutical company based in Lexington, MA. The company aims to redefine the regenerative medicine field by delivering therapeutics to any location in the body with precision. The company's clinical studies focus on the evaluation of amp2 coated rebossis for bone tissue regeneration. The company was founded by Luis Alvarez. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Luis Alvarez
| Unternehmen | Position | Ende |
|---|---|---|
Elevian, Inc.
 Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Gründer | - |
Ausbildung von Luis Alvarez
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Elevian, Inc.
Elevian, Inc. Pharmaceuticals: MajorHealth Technology Elevian, Inc. develops medicines that restore youthful regenerative capacity. The company was founded by Mark J. F. Allen, Sebastian Giwa, Peter H. Diamandis, Brock C. Reeve, and Luis Alvarez and is headquartered in Allston, MA. | Health Technology |
Theradaptive, Inc.
Theradaptive, Inc. Packaged SoftwareTechnology Services Theradaptive, Inc. is a venture-backed biopharmaceutical company based in Lexington, MA. The company aims to redefine the regenerative medicine field by delivering therapeutics to any location in the body with precision. The company's clinical studies focus on the evaluation of amp2 coated rebossis for bone tissue regeneration. The company was founded by Luis Alvarez. | Technology Services |
